Patents by Inventor W. Stratford May

W. Stratford May has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEOPLASIA
    Publication number: 20110110958
    Abstract: The invention provides compositions and methods for the treatment of neoplasias that are cytotoxic to neoplastic cells or that modulate JAZ expression, subcellular localization, or biological activity.
    Type: Application
    Filed: September 11, 2008
    Publication date: May 12, 2011
    Applicant: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION
    Inventors: Jingxin Qiu, Mingli Yang, David A. Ostrov, W. Stratford May
  • Modulating angiogenesis
    Patent number: 7491389
    Abstract: Hemangioblasts in adult bone marrow participate in new blood vessel formation. By modulating the differentiation of hemangioblasts into blood vessel cells, angiogenesis in a particular tissue can be increased or decreased. Intravitreal injection of antibodies that block SDF-1 activity inhibited induced retinal neovascularization mediated by hemangioblasts.
    Type: Grant
    Filed: March 18, 2003
    Date of Patent: February 17, 2009
    Assignee: University of Florida Reasearch Foundation, Inc.
    Inventors: Edward W. Scott, Maria Grant, W. Stratford May
  • Modulating angiogenesis
    Publication number: 20030180265
    Abstract: Hemangioblasts in adult bone marrow participate in new blood vessel formation. By modulating the differentiation of hemangioblasts into blood vessel cells, angiogenesis in a particular tissue can be increased or decreased. Intravitreal injection of antibodies that block SDF-1 activity inhibited induced retinal neovascularization mediated by hemangioblasts.
    Type: Application
    Filed: March 18, 2003
    Publication date: September 25, 2003
    Inventors: Edward W. Scott, Maria Grant, W. Stratford May
  • Stimulation of stem cell growth by the bryostatins
    Patent number: 5358711
    Abstract: In vivo and in vitro methods are taught for stimulating the differentiation of stem cells using certain bryostatins. Stem cells can be induced to form granulocytes, macrophages and erythrocytes. In addition, the cytotoxicity of mature neutrophils can be activated. These methods may substitute for those requiring human colony stimulating factors.
    Type: Grant
    Filed: September 10, 1993
    Date of Patent: October 25, 1994
    Assignee: Johns Hopkins University
    Inventors: W. Stratford May, Lyle L. Sensenbrenner